|
GMEB2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.9634999998418E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.1467000399511E-09 |
| Normal-vs-Stage2 |
7.226100E-02 |
| Normal-vs-Stage3 |
9.393200E-04 |
| Normal-vs-Stage4 |
1.362070E-02 |
| Stage1-vs-Stage2 |
2.889700E-02 |
| Stage1-vs-Stage3 |
1.025780E-02 |
| Stage1-vs-Stage4 |
7.166400E-04 |
| Stage2-vs-Stage3 |
6.423400E-01 |
| Stage2-vs-Stage4 |
8.973400E-01 |
| Stage3-vs-Stage4 |
3.716200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.6033000000435E-06 |
| Normal-vs-AfricanAmerican |
2.72209999996331E-06 |
| Normal-vs-Asian |
1.016210E-01 |
| Caucasian-vs-AfricanAmerican |
9.155000E-03 |
| Caucasian-vs-Asian |
2.383600E-01 |
| AfricanAmerican-vs-Asian |
8.744000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.647900E-04 |
| Normal-vs-Female |
1.35449984561831E-10 |
| Male-vs-Female |
3.77029999998335E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.806100E-02 |
| Normal-vs-Age(41-60Yrs) |
2.87210000005089E-07 |
| Normal-vs-Age(61-80Yrs) |
1.8425699999991E-05 |
| Normal-vs-Age(81-100Yrs) |
3.970300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.172400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.086000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.850200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.728800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.188200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.874400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.39860403445414E-11 |
| Normal-vs-Grade 2 |
2.15419999616273E-08 |
| Normal-vs-Grade 3 |
2.449400E-04 |
| Normal-vs-Grade 4 |
3.836100E-02 |
| Grade 1-vs-Grade 2 |
3.431400E-04 |
| Grade 1-vs-Grade 3 |
1.59669999999501E-06 |
| Grade 1-vs-Grade 4 |
2.58310000056383E-08 |
| Grade 2-vs-Grade 3 |
1.719510E-02 |
| Grade 2-vs-Grade 4 |
9.608700E-04 |
| Grade 3-vs-Grade 4 |
2.181800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.14369999529396E-09 |
| Normal-vs-ccB subtype |
2.392500E-02 |
| ccA subtype-vs-ccB subtype |
4.32429999996931E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.79950000000529E-05 |
| Normal-vs-N1 |
1.643240E-01 |
| N0-vs-N1 |
5.649400E-01 |
|
|
